The UK cannabis market is a web of contradictions and complexity. But, as GCNC founder, Chris Day finds out, organizations like Volteface are working tirelessly to change to narrative – and both public and political opinion. Chris chats with Paul North, director at Volteface; and Rifhat Jubeenh, from medical cannabis company, Fontus Health, and one of Volteface’s advisory board members.